Citigroup Inc. has filed an SEC document announcing the offering of $3.25 million in Trigger Callable Contingent Yield Notes. This offering is significant as it reflects the bank's ongoing efforts to attract investors with innovative financial products.
The notes are linked to the performance of the EURO STOXX 50, Nasdaq-100, and Russell 2000 indices. This structure allows Citigroup to provide investors with exposure to these major market indices while also presenting a unique investment opportunity.
Background
Citigroup Inc. is a leading financial institution categorized under the SIC code 6021, which stands for National Commercial Banks. The company operates primarily on the New York Stock Exchange (NYSE) with the ticker symbol 'C'. Recent filings include multiple forms submitted on October 29, 2026, indicating active engagement in the financial markets.
What the Filing Says
According to the recent SEC filing (accession number 0000950103-26-016414), the Trigger Callable Contingent Yield Notes are unsecured and unsubordinated debt obligations of Citigroup Global Markets Holdings Inc., guaranteed by Citigroup Inc. The notes will pay a contingent coupon on each quarterly payment date, provided that the closing levels of all underlying indices meet specified thresholds. If any underlying fails to meet its coupon barrier, no coupon will be paid for that period.
Impact
This offering may affect a wide range of investors, particularly those interested in structured products with contingent payouts. The notes are designed for investors who understand the risks associated with such investments, including the potential for loss of principal if the underlying indices perform poorly.
What's Next
The filing does not say what happens next.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










